Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Pro Medicus Limited
  6. Summary
    PME   AU000000PME8

PRO MEDICUS LIMITED

(PME)
  Report
Delayed Australian Stock Exchange  -  12:10:36 2023-01-30 am EST
65.86 AUD   +1.17%
01/20Pro Medicus Bags AU$25 Million Contract With University of Washington's UW Medicine
MT
2022Pro Medicus Secures Medical Imaging Deal in the US
MT
2022Transcript : Pro Medicus Limited - Shareholder/Analyst Call
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Australian Stock Exchange
01/23/2023 01/24/2023 01/25/2023 01/27/2023 01/30/2023 Date
63.23(c) 64.92(c) 64.5(c) 65.1(c) 65.86 Last
202 178 122 659 157 505 150 974 141 659 Volume
+1.79% +2.67% -0.65% +0.93% +1.17% Change
More quotes
Estimated financial data (e)
Sales 2023 118 M 84,0 M 84,0 M
Net income 2023 58,4 M 41,5 M 41,5 M
Net cash position 2023 91,9 M 65,3 M 65,3 M
P/E ratio 2023 116x
Yield 2023 0,42%
Sales 2024 144 M 102 M 102 M
Net income 2024 71,9 M 51,1 M 51,1 M
Net cash position 2024 123 M 87,2 M 87,2 M
P/E ratio 2024 93,6x
Yield 2024 0,52%
Capitalization 6 799 M 4 832 M 4 832 M
EV / Sales 2023 56,7x
EV / Sales 2024 46,5x
Nbr of Employees -
Free-Float 44,1%
More Financials
Company
Pro Medicus Limited is an Australia-based healthcare informatics company. The Company is a developer and supplier of healthcare imaging software and services to hospitals, diagnostic imaging groups and other related health entities in Australia, North America and Europe. The Company's products include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro and Visage Ease. Its Visage RIS is a Radiology Information... 
Read more
More about the company
Ratings of Pro Medicus Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about PRO MEDICUS LIMITED
01/20Pro Medicus Bags AU$25 Million Contract With University of Washington's UW Medicine
MT
2022Pro Medicus Secures Medical Imaging Deal in the US
MT
2022Transcript : Pro Medicus Limited - Shareholder/Analyst Call
CI
2022PRO MEDICUS LIMITED : Ex-dividend day for final dividend
FA
2022Pro Medicus Subsidiary Secures $11 Million Worth of Contracts in US
MT
2022Pro Medicus Limited Renews a 7-Year Contract with University of Florida
CI
2022Pro Medicus Raises Final Dividend Amid Increases in FY22 Profit, Revenue
MT
2022Transcript : Pro Medicus Limited, Q4 2022 Earnings Call, Aug 18, 2022
CI
2022Pro Medicus Limited Announces Fully Franked Ordinary Dividend for the Period of Twelve ..
CI
2022Pro Medicus Limited Reports Earnings Results for the Full Year Ended June 30, 2022
CI
2022Pro Medicus : Update - Notification of buy-back - PME
PU
2022Pro Medicus : Update - Notification of buy-back - PME
PU
2022Pro Medicus : Update - Notification of buy-back - PME
PU
2022Pro Medicus : Update - Notification of buy-back - PME
PU
2022Pro Medicus : Update - Notification of buy-back - PME
PU
More news
News in other languages on PRO MEDICUS LIMITED
01/20Pro Medicus décroche un contrat de 25 millions de dollars australiens avec l'UW Medicin..
2022Pro Medicus décroche un contrat d'imagerie médicale aux États-Unis
2022Une filiale de Pro Medicus obtient des contrats d'une valeur de 11 millions de dollars ..
2022Pro Medicus Limited renouvelle un contrat de 7 ans avec l'Université de Floride
2022Pro Medicus augmente son dividende final suite à l'augmentation de son bénéfice et de s..
More news
ETFs positioned on PRO MEDICUS LIMITEDETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
Fidelity Digital Health ACC - USD2.13%1.64%-NC
IShares S&P/ASX Small Ordinaries ETF - AUD1.21%1.09%-Australia
SPDR S&P/ASX Small Ordinaries Fund ETF - AUD0.86%1.17%-Australia
Vanguard MSCI Australian Small Companies In...0.7%0.82%-Australia
Russell Investments Australian Responsible ...0.53%1.10%-Australia
More ETFs positioned on PRO MEDICUS LIMITED
Chart PRO MEDICUS LIMITED
Duration : Period :
Pro Medicus Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PRO MEDICUS LIMITED
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Last Close Price 65,10 AUD
Average target price 54,02 AUD
Spread / Average Target -17,0%
EPS Revisions
Managers and Directors
Sam Aaron Hupert Chief Executive Officer, MD & Executive Director
Clayton James Hatch Secretary
Peter Terence Kempen Non-Executive Chairman
Anthony Barry Hall Executive Director & Technology Director
Malte Westerhoff Global Chief Technology Officer & GM-Europe
Sector and Competitors
1st jan.Capi. (M$)
PRO MEDICUS LIMITED17.81%4 832
VEEVA SYSTEMS INC.6.24%26 693
EVOLENT HEALTH, INC.11.36%3 116
SECTRA AB (PUBL)3.29%2 869
OMNICELL, INC.14.12%2 569
B-SOFT CO.,LTD.19.47%2 148